<?xml version="1.0" encoding="UTF-8"?>
<p>T cell responses against Zaire Ebola GP were assessed using ex vivo (18-h stimulation) IFN-Î³ ELISPOT assays as previously described (
 <xref rid="bib63" ref-type="bibr">Venkatraman et al., 2018</xref>). Assays were conducted using fresh PBMCs, therefore performed in Oxford for the UK cohort and in Dakar for the Senegalese cohort. The same protocol was used for both cohorts, and a thorough process of technology transfer and training was conducted before study commencement to minimize assay variation between the trial sites.
</p>
